Sign in
Home
Biotech Insights
Biotech News
CEO Interviews
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in / Join
About Us
Privacy Policy
Disclaimer
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Home
Biotech Insights
Biotech News
CEO Interviews
CEO Interviews
BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.
CEO Interviews
BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).
CEO Interviews
BriaCell Therapeutics (BCTXF) Presents Positive Efficacy Data with Lead Cancer Drug Candidate
CEO Interviews
Hemispherx Biopharma (HEB) Showing Strong Progress in Clinical Trials
CEO Interviews
Innovus Pharmaceuticals Continues Strong Revenue Growth & New Product Rollouts
BioTechStockTrader
About Biotech Stocktrader
Alernative Pharma
Biotech Insights
Biotech News
CEO Interviews
COVID-19
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Algernon Announces Enrollment of First U.S. Patient in Multinational Phase 2b/3 Human Study of Ifenprodil for Treatment of COVID-19
Therma Bright Inc.
-
August 13, 2020
0
Cognetivity Neurosciences presents at virtual Alzheimer’s Association International Conference (AAIC) 2020
Therma Bright Inc.
-
August 13, 2020
0
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Publication on the Use of Excellagen® for Vascular Repair
Therma Bright Inc.
-
August 13, 2020
0
Biotech News
Home
Biotech News
Page 2
Biotech News
Therma Bright Announces Closing of Over-Subscribed Private Placement for $1,250,000
Therma Bright Inc.
-
August 7, 2020
0
Biotech News
XORTX Appoints Dr. David Sans in New York as Director Corporate...
XORTX Therapeutics Inc.
-
August 7, 2020
0
Biotech News
Algernon Announces Enrollment of First Patient in 2b/3 Human Study of...
Algernon Pharmaceuticals Inc.
-
August 6, 2020
0
Biotech News
XORTX Partners with Mount Sinai’s Icahn School of Medicine on US-based...
XORTX Therapeutics Inc.
-
August 5, 2020
0
1
2
3
...
19
Page 2 of 19
- Advertisement -
APPLE
ARCA Biopharma Announces Program for COVID-19 Blood Clotting Treatment
XORTX Therapeutics Inc.
-
June 4, 2020
0
Biotech Insights
Based in Westminster, Colorado, ARCA biopharma (NASDAQ:ABIO) announced a new development program for the treatment of coagulopathy, or abnormal blood clotting, in patients with...
RECENT POSTS
Algernon Announces Enrollment of First U.S. Patient in Multinational Phase 2b/3 Human Study of...
XORTX Therapeutics Inc.
-
August 13, 2020
Cognetivity Neurosciences presents at virtual Alzheimer’s Association International Conference (AAIC) 2020
XORTX Therapeutics Inc.
-
August 13, 2020
Generex Biotechnology Subsidiary Olaregen Therapeutix Announces Publication on the Use of Excellagen® for Vascular...
XORTX Therapeutics Inc.
-
August 13, 2020
NEUTRISCI INTERNATIONAL INC. RELEASES UPDATE REGARDING PRODUCT LAUNCH IN CALIFORNIA
XORTX Therapeutics Inc.
-
August 12, 2020
Edit with Live CSS
